Reply.

Awan, Ahmed A;Jadoul, Michel;Martin, Paul
(2022) Clinical Gastroenterology and Hepatology — Vol. 20, n° 1, p. 247 (2022)

Files

AwanetalReplyClingastroenterologyandHepatol.pdf
  • Open Access
  • Adobe PDF
  • 59.67 KB
Download

Details

Authors
Abstract
(en) We thank Dai and coworkers for their interest in our article and for their valuable comments. As we noted in our article, sofosbuvir-velpatasvir-based regimens were not formally reviewed by the Evidence Review Team at the time of guideline publication. However, the Food and Drug Administration has recently indicated that no dose adjustments are required for these regimens in patients with chronic kidney disease including those on dialysis. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Awan, A. A., Jadoul, M., & Martin, P. (2022). Reply. Clinical Gastroenterology and Hepatology, 20(1), 247. https://doi.org/10.1016/j.cgh.2021.03.033 (Original work published 2022)